Abstract
Within the last decade, Drosophila has emerged as a premiere model system for the study of human neurodegenerative diseases, due to the realization that flies and humans share many structurally and functionally related gene families. Development of such disease models in the fly allows genetic approaches to be applied to address specific hypotheses concerning disease progression and to test candidate modifier genes. More recently these fly models have also been used for drug discovery. Here, we describe how to utilize the existing fruit fly models of human neurological disorders to identify small-molecule leads that could potentially be further developed for therapeutic use.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andretic R et al (2008) Drosophila D1 dopamine receptor mediates caffeine-induced arousal. Proc Natl Acad Sci U S A 105:20392–20397
Bainton RJ et al (2000) Dopamine modulates acute responses to cocaine, nicotine and ethanol in Drosophila. Curr Biol 10:187–194
McClung C, Hirsh J (1998) Stereotypic behavioral responses to free-base cocaine and the development of behavioral sensitization in Drosophila. Curr Biol 8:109–112
Moore MS et al (1998) Ethanol intoxication in Drosophila: genetic and pharmacological evidence for regulation by the cAMP signaling pathway. Cell 93:997–1007
Nichols CD et al (2002) Hallucinogens and Drosophila: linking serotonin receptor activation to behavior. Neuroscience 115:979–984
Rothenfluh A, Heberlein U (2002) Drugs, flies, and videotape: the effects of ethanol and cocaine on Drosophila locomotion. Curr Opin Neurobiol 12:639–645
Satta R, Dimitrijevic N, Manev H (2003) Drosophila metabolize 1,4-butanediol into gamma-hydroxybutyric acid in vivo. Eur J Pharmacol 473:149–152
Wolf FW, Heberlein U (2003) Invertebrate models of drug abuse. J Neurobiol 54:161–178
Rubin GM, Spradling AC (1982) Genetic transformation of Drosophila with transposable element vectors. Science 218:348–353
Brand AH, Perrimon N (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401–415
McGuire SE, Roman G, Davis RL (2004) Gene expression systems in Drosophila: a synthesis of time and space. Trends Genet 20:384–391
Roman G et al (2001) P[Switch], a system for spatial and temporal control of gene expression in Drosophila melanogaster. Proc Natl Acad Sci U S A 98:12602–12607
Dietzl G et al (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448:151–156
Pollitt SK et al (2003) A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron 40:685–694
Desai UA et al (2006) Biologically active molecules that reduce polyglutamine aggregation and toxicity. Hum Mol Genet 15:2114–2124
Chang S et al (2008) Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4:256–263
Warren ST, Sherman SL (2001) The fragile X syndrome. In: Scriver CR, Beaudet al, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic & molecular bases of inherited disease. McGraw-Hill Companies, New York, pp 1257–1290
Sherman S (2002) Epidemiology. In: Hagerman RJ (ed) Fragile X syndrome: diagnosis, treatment and research. The Johns Hopkins University Press, Baltimore, MD, pp 136–168
Hagerman RJ, Hagerman PJ (2002) The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 12:278–283
Hagerman PJ, Hagerman RJ (2004) The fragile-X premutation: a maturing perspective. Am J Hum Genet 74:805–816
Jin P et al (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 39:739–747
Pulak R (2006) Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system. Methods Mol Biol 351:275–286
Ali YO et al (2011) Assaying locomotor, learning, and memory deficits in Drosophila models of neurodegeneration. J Vis Exp 49:2504
Scott R et al (2002) CREB and the discovery of cognitive enhancers. J Mol Neurosci 19:171–177
Branson K et al (2009) High-throughput ethomics in large groups of Drosophila. Nat Methods 6:451–457
Dankert H et al (2009) Automated monitoring and analysis of social behavior in Drosophila. Nat Methods 6:297–303
Acknowledgements
This work was supported by NIH grants (R01 NS051630 and R21 NS067461 to P.J.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Poidevin, M., Zhang, F., Jin, P. (2015). Small-Molecule Screening Using Drosophila Models of Human Neurological Disorders. In: Hempel, J., Williams, C., Hong, C. (eds) Chemical Biology. Methods in Molecular Biology, vol 1263. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2269-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2269-7_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2268-0
Online ISBN: 978-1-4939-2269-7
eBook Packages: Springer Protocols